Brief: Oncosil Medical Announces Entitlement Offer To Raise Up To A$9.9 Million
March 17 (Reuters) - Oncosil Medical Ltd OSL.AX :
* ENTITLEMENT OFFER TO RAISE UP TO A$9.9 MILLION
* ENTITLEMENT OFFER AT AN ISSUE PRICE OF A$0.01 PER NEW
SHARE
* UNDERTAKING NON-UNDERWRITTEN 1 FOR 1 NON-RENOUNCEABLE
ENTITLEMENT OFFER
* PROCEEDS FROM CAPITAL RAISING TO BE USED FOR MANUFACTURING
&
SUPPLY CHAIN OPTIMISATION PROJECTS, AMONG OTHERS
Source text for Eikon: ID:nASX6Mm4LV
Further company coverage: OSL.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Oncosil Medical
See all newsAustralia's OncoSil Medical gains most in over 2 months on reaching 100-th patient milestone
Brief: Oncosil Medical Says FDA Grants Hde Approval For Oncosil Device For Distal Cholangiocarcinoma
Brief: Oncosil Medical Posts FY26 Unit Sales Up 53%, Revenue Up 44% Versus FY25
Brief: Oncosil Medical Receives Saudi FDA Approval
Brief: Oncosil Medical Files For FDA Approval